Read about how uncontrolled #HIV viremia results in the progression to #AIDS, and how this can be stopped with #AntiretroviralTherapy (#ART) in the latest Journal of #Infection 👉 www.journalofinfecti...
August 13, 2025 at 9:09 AM
Read about how uncontrolled #HIV viremia results in the progression to #AIDS, and how this can be stopped with #AntiretroviralTherapy (#ART) in the latest Journal of #Infection 👉 www.journalofinfecti...
#pharma #HIV #GileadSciences #MSD #lenacapavir #islatravir #clinicaltrials #infectiousdiseases #Gilead #oralHIVtreatment #HIVtreatment #phase3trials #capsidinhibitor #ISLEND1trial #ISLEND2trial #antiretroviraltherapy #ART #FDA #Sunlenca #MDRHIV #HIVpreexposureprophylaxis #PrEP #NNRTI
zurl.co/gq0wN
zurl.co/gq0wN
Gilead, MSD share data on once-weekly oral HIV treatment
Gilead/MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral suppression in phase 3, setting up regulatory filings.
pharmaphorum.com
August 20, 2026 at 7:59 AM
newsspacezim.co.zw/2025/09/02/l... #HIV #Zimbabwe #NationalAidsCouncil #paediatric #health #ART #antiretroviraltherapy
Low ART coverage for children in Midlands Province - newsspace
NAC Manager for Midlands Province, Mambewu Shumba addresses the media BY MUNYARADZI BLESSING DOMA in KWEKWE Whilst the country has achieved the 95-95-95 UNAIDS targets to end AIDS by 2030, Midlands Pr...
newsspacezim.co.zw
September 4, 2025 at 5:45 PM
❗OUT NOW! In a translational research collaboration between @bqbiomedmolub.bsky.social & @irsantpau.bsky.social we identify ⬇️circulating #CXCL14 as a subclinical cardiovascular disease biomarker in people living with #HIV on #antiretroviraltherapy💊🫀
Open access here ➡️ doi.org/10.1016/j.ej...
Open access here ➡️ doi.org/10.1016/j.ej...
July 28, 2025 at 4:03 PM
❗OUT NOW! In a translational research collaboration between @bqbiomedmolub.bsky.social & @irsantpau.bsky.social we identify ⬇️circulating #CXCL14 as a subclinical cardiovascular disease biomarker in people living with #HIV on #antiretroviraltherapy💊🫀
Open access here ➡️ doi.org/10.1016/j.ej...
Open access here ➡️ doi.org/10.1016/j.ej...
Pleased to share our latest paper on DNA methylation and inflammation in people with HIV. We identify DNAm patterns linked to chronic inflammation in men with HIV, even on antiretroviraltherapy.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
A multi-trait epigenome-wide association study identified DNA methylation signature of inflammation among men with HIV - Clinical Epigenetics
Inflammation underlies many conditions causing excess morbidity and mortality among people with HIV (PWH). A handful of single-trait epigenome-wide association studies (EWAS) have suggested that infla...
link.springer.com
November 3, 2024 at 9:18 PM
Pleased to share our latest paper on DNA methylation and inflammation in people with HIV. We identify DNAm patterns linked to chronic inflammation in men with HIV, even on antiretroviraltherapy.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
📈 Among children living with #HIV in 13 sub-Saharan African countries, maternal HIV care engagement was associated with higher child viral suppression primarily through increased #AntiretroviralTherapy uptake. ja.ma/4xb7t1I
Maternal Engagement in HIV Care and ART Uptake Among Children With HIV
This cross-sectional study examines the role of antiretroviral therapy (ART) use and viral load suppression among mothers in their children’s viral load suppression in sub-Saharan Africa.
ja.ma
September 10, 2026 at 1:30 PM
📈 Among children living with #HIV in 13 sub-Saharan African countries, maternal HIV care engagement was associated with higher child viral suppression primarily through increased #AntiretroviralTherapy uptake. ja.ma/4xb7t1I
Don't miss your chance to be part of an inspiring event! Submit your abstract or scholarship application by Jan.14th (11:59pm MST) and join Steven Deeks along with other incredible speakers this April in Durban, South Africa! keysym.us/KSHIV25 #KSHIV25 #HIVcure #HIVvaccine #antiretroviraltherapy
December 25, 2024 at 7:59 PM
Don't miss your chance to be part of an inspiring event! Submit your abstract or scholarship application by Jan.14th (11:59pm MST) and join Steven Deeks along with other incredible speakers this April in Durban, South Africa! keysym.us/KSHIV25 #KSHIV25 #HIVcure #HIVvaccine #antiretroviraltherapy
From @ofidjournal.bsky.social 🦠
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
Dolutegravir Improves Long-Term HIV Outcomes in Children and Adolescents
Among pediatric patients with HIV, DTG-based ART showed superior efficacy compared with standard care regimens over 240 weeks.
www.infectiousdiseaseadvisor.com
June 17, 2026 at 7:24 PM
From @ofidjournal.bsky.social 🦠
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
📢 A global meta-analysis in published Nature Communications reveals that post-treatment HIV control is rare but more likely with early ART and high CD4+ T cells.🔗 Read more:
www.epivinf.eu/2025/02/11/i...
#HIV #AntiretroviralTherapy #ClinicalTrials
www.epivinf.eu/2025/02/11/i...
#HIV #AntiretroviralTherapy #ClinicalTrials
Interruption of HIV treatment: a new study guides the design of future clinical trials for an HIV cure – EPIVINF
www.epivinf.eu
February 13, 2025 at 7:40 AM
📢 A global meta-analysis in published Nature Communications reveals that post-treatment HIV control is rare but more likely with early ART and high CD4+ T cells.🔗 Read more:
www.epivinf.eu/2025/02/11/i...
#HIV #AntiretroviralTherapy #ClinicalTrials
www.epivinf.eu/2025/02/11/i...
#HIV #AntiretroviralTherapy #ClinicalTrials
Nearly half of all #children living with #HIV have no access to #antiretroviraltherapy in 2025. This is preventable, treatable — and we're failing them. Budget cuts, criminalisation, inequity. We can do better.
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
HIV funding cut by a fifth: UNAIDS warns of epidemic resurgence as 570,000 AIDS deaths recorded in 2025 ➜ ZMINA
HIV funding cut by a fifth: UNAIDS warns of epidemic resurgence as 570,000 AIDS deaths recorded in 2025 UNAIDS estimates that 20 million people need access to antiretroviral-based prevention to have a...
zmina.info
July 28, 2026 at 11:50 AM
Nearly half of all #children living with #HIV have no access to #antiretroviraltherapy in 2025. This is preventable, treatable — and we're failing them. Budget cuts, criminalisation, inequity. We can do better.
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
📢New article alert
New research in JCER examines B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HIV #HIVCare #AntiretroviralTherapy #CER
New research in JCER examines B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HIV #HIVCare #AntiretroviralTherapy #CER
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis
Aim: Bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF) is a single-tablet
regimen approved for the treatment of HIV-1 in treatment-naive (TN) and virologically
suppressed people with...
becarispublishing.com
June 12, 2025 at 11:19 AM
📢New article alert
New research in JCER examines B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HIV #HIVCare #AntiretroviralTherapy #CER
New research in JCER examines B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HIV #HIVCare #AntiretroviralTherapy #CER
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
2.7 Million Malians Blocked From HIV Treatment
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
news.gmj.ge
September 21, 2026 at 1:27 AM
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
Early metabolic risk evaluation and preventive measures at #AntiretroviralTherapy initiation are critical for managing age-related comorbidities in people with #HIV.
Obesity at ART Initiation May Increase Long-Term Clinical Risk in HIV
Baseline obesity in adults initiating ART may worsen long-term comorbidity and mortality risks, particularly in younger patients.
www.infectiousdiseaseadvisor.com
September 16, 2026 at 7:11 PM
Early metabolic risk evaluation and preventive measures at #AntiretroviralTherapy initiation are critical for managing age-related comorbidities in people with #HIV.
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
2.7 Million Malians Blocked From HIV Treatment
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
news.gmj.ge
September 10, 2026 at 4:41 AM
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
From @ofidjournal.bsky.social 🦠
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
Dolutegravir Plus Lamivudine Matches 3-Drug ART in Treatment-Naive HIV-1
DTG/3TC achieves noninferior virologic suppression when compared with BIC/FTC/TAF in adults initiating first-line ART for HIV-1.
www.infectiousdiseaseadvisor.com
August 21, 2026 at 6:19 PM
From @ofidjournal.bsky.social 🦠
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
Breaking: NHS emergency department HIV testing has identified 1,953 previously undiagnosed cases over four years across 88 English areas. The opt-out screening p…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
NHS A&E HIV Testing: 1,953 Cases Diagnosed
Breaking: NHS emergency department HIV testing has identified 1,953 previously undiagnosed cases over four years across 88 English areas. The opt-out screening p…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
news.gmj.ge
August 10, 2026 at 3:29 PM
Breaking: NHS emergency department HIV testing has identified 1,953 previously undiagnosed cases over four years across 88 English areas. The opt-out screening p…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
During the Tigray War, #HIV diagnoses, linkage to care, and #AntiretroviralTherapy initiation in Mekelle declined substantially compared with prewar trends.
ja.ma/4cfXY9P
ja.ma/4cfXY9P
August 2, 2026 at 5:24 AM
During the Tigray War, #HIV diagnoses, linkage to care, and #AntiretroviralTherapy initiation in Mekelle declined substantially compared with prewar trends.
ja.ma/4cfXY9P
ja.ma/4cfXY9P
From @cidjournal.bsky.social 🦠
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Long-Acting ART Achieves HIV Virologic Suppression in Patients With Viremia
Real-world data demonstrate high rates of viral suppression among PWH with viremia who initiate LA CAB/RPV.
www.infectiousdiseaseadvisor.com
July 31, 2026 at 2:24 PM
From @cidjournal.bsky.social 🦠
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
People with #HIV who have never been on #AntiRetroviralTherapy have a notable prevalence of #CardiometabolicDiseases, indicating a cardiometabolic burden is present prior to ART initiation.
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
June 17, 2026 at 9:45 PM
People with #HIV who have never been on #AntiRetroviralTherapy have a notable prevalence of #CardiometabolicDiseases, indicating a cardiometabolic burden is present prior to ART initiation.
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
[Publication] The article "Real-life evaluation of intermittent triple antiretroviral therapy maintenance strategies" is now available.
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
Real-life evaluation of intermittent triple antiretroviral therapy maintenance strategies
Intermittent antiretroviral therapy (ART) is commonly prescribed in France, but this strategy is not recommended internationally. The objective of thi…
www.sciencedirect.com
October 6, 2025 at 6:58 AM
[Publication] The article "Real-life evaluation of intermittent triple antiretroviral therapy maintenance strategies" is now available.
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
2➡️ Un article original cherchant à estimer les rapports de risque de mortalité précoce chez des PVVIH ayant commencé un traitement antirétroviral..
www.sciencedirect.com/science/arti...
#IDSky #AntiretroviralTherapy #HIVMortalityRate #SurvivalStudy #Senegal
www.sciencedirect.com/science/arti...
#IDSky #AntiretroviralTherapy #HIVMortalityRate #SurvivalStudy #Senegal
February 3, 2025 at 8:12 AM
2➡️ Un article original cherchant à estimer les rapports de risque de mortalité précoce chez des PVVIH ayant commencé un traitement antirétroviral..
www.sciencedirect.com/science/arti...
#IDSky #AntiretroviralTherapy #HIVMortalityRate #SurvivalStudy #Senegal
www.sciencedirect.com/science/arti...
#IDSky #AntiretroviralTherapy #HIVMortalityRate #SurvivalStudy #Senegal
[#ListeDeLecture] Nouveau mois, nouvelle liste de lecture ! Nous vous proposons donc une sélection d’articles sur le thème des anti-infectieux.
C'est parti !⬇️
#IDSky #Antibiotics #AntiretroviralTherapy #HIV #Covid19 #AntiviralAgents #TherapeuticUse #PublicHealth #AntiFungal
C'est parti !⬇️
#IDSky #Antibiotics #AntiretroviralTherapy #HIV #Covid19 #AntiviralAgents #TherapeuticUse #PublicHealth #AntiFungal
a bunch of red and white pills are falling from the sky .
ALT: a bunch of red and white pills are falling from the sky .
media.tenor.com
February 3, 2025 at 8:12 AM
[#ListeDeLecture] Nouveau mois, nouvelle liste de lecture ! Nous vous proposons donc une sélection d’articles sur le thème des anti-infectieux.
C'est parti !⬇️
#IDSky #Antibiotics #AntiretroviralTherapy #HIV #Covid19 #AntiviralAgents #TherapeuticUse #PublicHealth #AntiFungal
C'est parti !⬇️
#IDSky #Antibiotics #AntiretroviralTherapy #HIV #Covid19 #AntiviralAgents #TherapeuticUse #PublicHealth #AntiFungal
🚨 NEW RESEARCH! ⚕️ 🩺
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1 - Communications Medicine
Fernandez et al. compare the HTLV-1 proviral load in people with HIV-1-HTLV-1 coinfection on stable antiretroviral therapy or people with HTLV-1 single infection without antiretroviral therapy. Dolutegravir use for longer than six months is associated with lower HTLV-1 proviral load.
dlvr.it
March 5, 2026 at 12:37 PM
🚨 NEW RESEARCH! ⚕️ 🩺
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
‘Breakthrough of the Year’ drug for HIV care
#Health #HIV #Lenacapavir #BreakthroughDrug #HIVCare #GlobalHealth #AntiretroviralTherapy #MedicalInnovation #HIVAwareness #HealthcareAccess #HIVAIDS
the-14.com/breakthrough...
#Health #HIV #Lenacapavir #BreakthroughDrug #HIVCare #GlobalHealth #AntiretroviralTherapy #MedicalInnovation #HIVAwareness #HealthcareAccess #HIVAIDS
the-14.com/breakthrough...
the-14.com
January 1, 2025 at 8:21 PM
‘Breakthrough of the Year’ drug for HIV care
#Health #HIV #Lenacapavir #BreakthroughDrug #HIVCare #GlobalHealth #AntiretroviralTherapy #MedicalInnovation #HIVAwareness #HealthcareAccess #HIVAIDS
the-14.com/breakthrough...
#Health #HIV #Lenacapavir #BreakthroughDrug #HIVCare #GlobalHealth #AntiretroviralTherapy #MedicalInnovation #HIVAwareness #HealthcareAccess #HIVAIDS
the-14.com/breakthrough...
#ViiV #Pfizer #ViiVHealthcare #Shionogi #HIV #GSK #strategicpartnership #jointventure #HIVtherapies #GileadSciences #HIVtreatment #antiretroviraltherapy #longeractinginjectableregimens #HIVpreexposureprophylaxis #PrEP #preexposureprophylaxis #Apretude #cabotegravir #lenacapavir
zurl.co/khJ6D
zurl.co/khJ6D
ViiV ownership shifts as Pfizer sells its stake
Pfizer will relinquish its stake in HIV firm ViiV in a deal valued at $2.1bn that ramps up Shionogi's interest and simplifies its share structure
pharmaphorum.com
January 27, 2026 at 11:46 AM